← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2014Last known activity
Sep 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (16 distinct, 10 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Other trials (10 own, 0 via acquisition)
Indications
Recent trials (19)
- NCT07295691Sponsor investigatorN/ASep 1, 2025
- NCT07295691Lead sponsorN/ASep 1, 2025
- NCT07021170Lead sponsorPhase 4Jun 15, 2025
- NCT07021170Sponsor investigatorPhase 4Jun 15, 2025
- NCT06928844Sponsor investigatorN/AApr 15, 2025
- NCT06928844Lead sponsorN/AApr 15, 2025
- NCT06787924Lead sponsorN/AApr 7, 2025
- NCT06787924Sponsor investigatorN/AApr 7, 2025
- NCT06510452Lead sponsorN/AOct 1, 2024
- NCT06510452Sponsor investigatorN/AOct 1, 2024
- NCT06049758Reponsible party - principal investigatorN/AJan 2, 2024
- NCT06049758Lead sponsorN/AJan 2, 2024
- NCT07077525CollaboratorPhase 4Jun 1, 2023
- NCT05285397Lead sponsorN/AMar 10, 2022
- NCT05285397Reponsible party - principal investigatorN/AMar 10, 2022
Details
- Last known activity
- Sep 1, 2025